Ubrolexin intramammary suspension for lactating dairy cows Irland - engelsk - HPRA (Health Products Regulatory Authority)

ubrolexin intramammary suspension for lactating dairy cows

boehringer ingelheim vetmedica gmbh - cefalexin monohydrate; kanamycin monosulphate - intramammary suspension - 200 mg/100,000 iu per syringe - cefalexin, combinations with other antibacterials - cattle - antibacterial

Ubrolexin 13,3 mg/g - 20 mg/g i.mamm. susp. pre-filled syr. Belgien - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ubrolexin 13,3 mg/g - 20 mg/g i.mamm. susp. pre-filled syr.

boehringer ingelheim vetmedica gmbh - kanamycin sulfate 13,3 mg/g - eq. kanamycin 10000 iu/g; cefalexin monohydrate - eq. cefalexin 20 mg/g - intramammary suspension - 13,3 mg/g - 20 mg/g - cefalexin monohydrate; kanamycin (mono)sulfate - cefalexin, combinations with other antibacterials - cattle

Firehawk Liberty Rapamycin Target Eluting Coronary Stent System - Drug-eluting coronary artery stent, biodegradable-polymer-coated Australien - engelsk - Department of Health (Therapeutic Goods Administration)

firehawk liberty rapamycin target eluting coronary stent system - drug-eluting coronary artery stent, biodegradable-polymer-coated

microport crm pty ltd - 58771 - drug-eluting coronary artery stent, biodegradable-polymer-coated - the product is a device/drug combination product consisting of a) a stent coated with rapamycin in a biodegradable polymer which filled in grooves on the outer surface of stent struts; and b)a rapid exchange (rx) delivery catheter. the stent is left in the vessel to permanently support the vessel. rapamycin is abluminal on stent struts and is slowly eluted to inhibit proliferation of smooth muscle cells. the coating will degrade and eventually the stent becomes a metal stent. the firehawk liberty? rapamycin target eluting coronary stent system is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions (length ? 60 mm) with reference vessel diameters of ? 2.25 to ? 4.0 mm.

Firehawk Rapamycin Target Eluting Coronary Stent System - Drug-eluting coronary artery stent, biodegradable-polymer-coated Australien - engelsk - Department of Health (Therapeutic Goods Administration)

firehawk rapamycin target eluting coronary stent system - drug-eluting coronary artery stent, biodegradable-polymer-coated

microport crm pty ltd - 58771 - drug-eluting coronary artery stent, biodegradable-polymer-coated - the product is a balloon expandable stent with grooves on the outer surface of stent struts. the grooves are coated with a biodegradable drug (rapamycin)/polymer(dl-pla) matrix. the delivery system is a rapid exchange (rx) balloon catheter with effective working length of 140 cm. the firehawk rapamycin target eluting coronary stent system is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions length ? 60 mm with reference vessel diameters of ? 2.25 to ? 4.0 mm.

Kanamac 1000 Namibia - engelsk - Namibia Medicines Regulatory Council

kanamac 1000

macleods pharmaceuticals ltd - kanamycin acid sulphate - injection vial - each vial contains kanamycin acid sulphate bp equivalent to kanamycin base 1g

N-Mycin 50 mg/mL (5% w/v) Ophthalmic Suspension (Eye Drops) Filippinerne - engelsk - FDA (Food And Drug Administration)

n-mycin 50 mg/ml (5% w/v) ophthalmic suspension (eye drops)

n/a; importer: sahar international trading inc.; distributor: sahar international trading inc. - natamycin - ophthalmic suspension (eye drops) - 50 mg/ml (5% w/v)